Serum uric acid (SUA) may play an important role in the occurrence of colorectal cancer
(CRC). This study aims to explore the association of SUA with the risk of CRC incidence by …

Elevated serum uric acid (SUA) levels have been previously reported to play a role in
multiple types of cancers. However, epidemiological studies evaluating SUA levels and …

Objective Pathogenesis of colorectal cancer (CRC) depends on multiple factors. Identifying
risk factors for CRC may facilitate the early prevention of the disease. We aimed to assess …

Background A meta-analysis was performed in this study to evaluate the association
between serum uric acid and the risk of colorectal cancer (CRC). Methods Relevant …

Elevated serum uric acid (SUA) is a marker of chronic inflammation and has been suggested
to be associated with increased risk of cancer, but its antioxidant capacity would justify an …

SUA is a potent antioxidant and thus may play a protective role against cancer. Many
epidemiological studies have investigated this hypothesis but provided inconsistent and …

BACKGROUND Uric acid is the end product of purine metabolism. Previous studies have
found that serum uric acid (SUA) levels are associated with the total cancer risk. However …

Purpose Serum uric acid (SUA) has antioxidant capacities and therefore may protect against
the development of cancer. Few epidemiological studies have tested this hypothesis, and …

Dysregulation of the urea cycle (UC) has been detected in colorectal cancer (CRC).
However, the impact of the UC's end product, urea, on CRC development remains unclear …

Objective To examine the prognostic role of serum uric acid (SUA) for cancer mortality in
apparently healthy men across a wide age range. Methods Prospective data from a large …